Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Q Liu, C Qin, M Liu, J Liu - Infectious diseases of poverty, 2021 - mednexus.org
Background: To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …
[HTML][HTML] Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
K Bok, S Sitar, BS Graham, JR Mascola - Immunity, 2021 - cell.com
The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …
[HTML][HTML] Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Background Vaccine effectiveness studies have not differentiated the effect of the delta (B.
1.617. 2) variant and potential waning immunity in observed reductions in effectiveness …
1.617. 2) variant and potential waning immunity in observed reductions in effectiveness …
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …
Public health impact of covid-19 vaccines in the US: observational study
Objective To evaluate the impact of vaccine scale-up on population level covid-19 mortality
and incidence in the United States. Design Observational study. Setting US county level …
and incidence in the United States. Design Observational study. Setting US county level …
[HTML][HTML] Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell
responses that continue to evolve for at least a year. During that time, memory B cells …
responses that continue to evolve for at least a year. During that time, memory B cells …
[HTML][HTML] Effectiveness of mRNA Covid-19 vaccine among US health care personnel
T Pilishvili, R Gierke, KE Fleming-Dutra… - … England Journal of …, 2021 - Mass Medical Soc
Background The prioritization of US health care personnel for early receipt of messenger
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS …
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS …
[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
[HTML][HTML] New COVID-19 cases and hospitalizations among adults, by vaccination status—New York, May 3–July 25, 2021
ES Rosenberg - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against
hospitalization in New York was relatively stable (91.9%–95.3%). The overall age-adjusted …
hospitalization in New York was relatively stable (91.9%–95.3%). The overall age-adjusted …
Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021
Importance The number of SARS-CoV-2 infections and COVID-19–associated
hospitalizations and deaths prevented among vaccinated persons, independent of the effect …
hospitalizations and deaths prevented among vaccinated persons, independent of the effect …